Human papillomavirus infections in women with and without squamous cell abnormalities of the uterine cervix
Abstract
Introduction: Human papillomavirus infections are one of the most common sexually transmitted infections with viral etiology.
Aim of the study: The aim of the study was to confirm the existence of an association between human papillomavirus infection and squamous cell abnormalities of the uterine cervix.
Material and Methods: Cohort study, conducted in the period from January 2017 to June 2018 of 768 sexually active women, age groups of 20 to 59 years, divided into two groups: examined and control, who came to their annual gynecological exam at University Clinic for Gynecology and Obstetrics in Skopje. In all patients was done human papillomavirus-deoxyribonucleic testing. Human papillomavirus detection and typing was done using a polymerase chain reaction and reverse hybridization.
Results: Data analysis showed an association between human papillomavirus infection and squamous cell abnormalities of the uterine cervix (p=0.00001). Human papillomavirus infection was detected in 22.91% of all patients, in 75.00% of patients with abnormal cervical cytology and in 12.50% of patients with normal cervical cytology. A single human papillomavirus infection was detected in 13.67% of all patients (in 59.66% of human papillomavirus positive patients). Mixed human papillomavirus infection was detected in 9.24% of all patients (in 40.34% of human papillomavirus positive patients). Human papillomavirus type 16 was the most common genotype with 40.91%.
Conclusion: Our study confirmed that there is an association between human papillomavirus infection and squamous cell abnormalities of the uterine cervix and the young population under the age of 30 years is the most affected.
Keywords: human papillomavirus, squamous cell abnormalities, uterine cervix
References
Pirrota M, Ung L, Stein A, Mast TC. The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect 2009; 85:508-513.
Pierce CM, Menezes LJ, Paskett ED, Giuliano AR. Prevention of invasive cervical cancer in the United States: past, present and future. Cancer Epidemiol Biomarkers Prev 2012; 21(9):1402-8.
Cuzick J, Clavel C, Petry K, Meijer CJLM, Hoyer H, Ratnam S, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International Journal of Cancer 2006; 119(5):1095-1101.
Lau S, Franco EL. Management of low-grade cervical lesions in young women. Canadian Medical Association Journal 2005; 173(7):771-774.
Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology 2002; 55(4):244-265.
zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews Cancer 2002; 2(5):342-350.
Brink AATP, Snijders PJF, Meijer CJLM. HPV Detection Methods. Disease Markers 2007; 23(4):273-281.
Zerat L. La nouvelle terminologie de Bethesda: quellschangements. Rev Prat Gynecol Obstet 2002 3-10; Numero Special.
Solomon D, Davey D, Kurman R. The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology. JAMA 2002; 287(16).
Franco EL. Chapter 13: Primary Screening of Cervical Cancer with Human Papillomavirus Tests. JNCI Monographs 2003; 2003(31):89-96.
Sweet RL, Gibbs RS. Infectious disease of the female genital tract. Philadelphia, USA: Wolters Kluwer Health. Lippincott Williams & Wilkins; 2009.
Vieira L, Almeida A.The cytology and DNA detection by the Papillo Check test in the diagnosis of human papillomavirus infection. Eur J Microbiol Immunol 2013; 3(1):61-7.
Mazarico E, Gonzalez-Bosquet E. Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology. Gynecol Oncol 2012; 125(1):181-5.
Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Group. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study. Int J Gynecol Cancer 2013; 23(3):500-6.
Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202(12):1789-99.
Anderson L, O’Rorke M, Jamison J, Wilson R, Gavin A. Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis. J Med Virol 2013; 85(2):295-308.
Bao YP, Li N, Smith JS, Qiao YL. Human papillomavirus type-distribution I the cervix of Chinese women: a meta-analysis. Int J STD AIDS 2008; 19(2):106-11.
Balanda M, Quiero A, Vergara N, Espinoza G, Martin HS, Rojas G, Ramirez E. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. Med Microbio Immunol 2016; 205(6):585-594.
Garcia-Garcia JA, Perez-Valles A, Martorell M, Gomez B, Gomez-Cabrero D, Soler F, Calabuiq C. Distribution of human papillomavirus types in women from Valencia, Spain, with abnormal cytology. Acta Cytol 2010; 54(2):159-64.
Agodi A, Barchitta M, La Rosa N, Cipresso R, Guarnaccia M, Castiqlione MG, Ettore G, Travali S. Human papillomavirus infection: low-risk and high-risk genotypes in women in Catania, Sicily. Int J Gynecol Cancer 2009; 19(6):1094-8.
Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K. Distribution of human papillomavirus types inThin Prep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006; 106(5):1054-64.
Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Steinau M, Markovitz LE; HPV-IMPACT Working Group. Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis 2012; 206(12):1878-86.
Sandri MT, Riggio D, Salvatici M, Passerin R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M. Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol 2009; 81(2):271-7.
Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E. Multiple high riski HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004; 57(1):68-72.
Vujosevic D, Vuksanovic V, Poljak M, Jokmanovic N. Human papillomavirus genotype spectrum in studied group of Montenegrin women. Acta Medica (Hradec Kralove) 2012; 55(3):130-2.
Kovačević G, Jovanović-Galović A, Petrović V, Vinarž Z, G Marinković G, Brašanac B, Milošević V. Human papillomavirus infection prevalence in female university students in Novi Sad, Serbia. Srp Arh Celok Lek 2016; 144(5-6):300-306.
Grozdanov P, Zlatkov V, Ganchev G, Karagiosov I, Toncheva D, Galabov AS. HPV prevalence and type distribution in women with normal or abnormal Pap smear in Bulgaria. J Med Virol 2014; 88(11):1905-10.
Kovachev S, Slavov V, Slavova K. Prevalence of human papillomavirus infection in women in some cities and regions of Bulgaria. J Med Virol 2013; 85(9):1577–84.
Moga MA, Irimi, M, Oanta A, Pascu A, Burtea V. Type-specific Prevalence of Human Papillomavirus by Cervical Cytology among Women in Brasov, Romania. Asian Pac J Cancer Prev 2014; 15(16):6887–92.
Andonovska J. Genotyping distribution and prevalence of the HPV infection in Macedonia. Int J Infect Dis 2014; 21(1):398.
Стојановска В, Панов С, Башеска Н, Јосифовска С, Димитров Г, Петановски З, Стојковски Ј, Хаџи-Лега М. Преваленција и дистрибуција на хуман папилома вирус инфекција кај клинички суспектни цервикални лезии. Мак Мед Преглед 2009;63(1):17-24.
Дувлис С. Генотипизација на хуман папилома вирус (ХПВ) кај женската популација во Република Македонија. Магистерски труд. Универзитет Св. Кирил и Методиј, Интердисциплинарни постдипломски студии по молекуларна биологија и генетско инженерство, Скопје 2000.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).